Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Unresectable Soft Tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02500797
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Who this might be right for
Locally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more
National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)UnknownNCT00033709
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma

Who this might be right for
Sarcoma
Herbert Irving Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT03002805
What this trial is testing

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

Who this might be right for
Sarcoma
CBA Research 46
Testing effectiveness (Phase 2)Ended earlyNCT01876043
What this trial is testing

Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial

Who this might be right for
Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma
Institut Bergonié 24
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Active Not RecruitingNCT04299113
What this trial is testing

Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma

Who this might be right for
Rhabdomyosarcoma
Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Ended earlyNCT03468075
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
Mohammed Milhem, MBBS 10
Large-scale testing (Phase 3)Study completedNCT02049905
What this trial is testing

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Who this might be right for
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
ImmunityBio, Inc. 433
Early research (Phase 1)Ended earlyNCT04627142
What this trial is testing

Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Boehringer Ingelheim 15
Testing effectiveness (Phase 2)Study completedNCT01222767
What this trial is testing

Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy

Who this might be right for
Ewing's SarcomaPrimitive Neuroectodermal Tumor (PNET)Askin's Tumor of the Chest Wall+1 more
PharmaMar 17
Testing effectiveness (Phase 2)UnknownNCT05189483
What this trial is testing

Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.

Who this might be right for
Soft Tissue Sarcoma
Henan Cancer Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT01059656
What this trial is testing

Phase II Pazopanib Study in Advanced Dermatofibrosarcomas

Who this might be right for
Dermatofibrosarcomas of DARIER FERRAND(DFSP)
Assistance Publique - Hôpitaux de Paris 23
Testing effectiveness (Phase 2)Study completedNCT00148109
What this trial is testing

Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas

Who this might be right for
Sarcoma
University of Michigan Rogel Cancer Center 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07156643
What this trial is testing

A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma.

Who this might be right for
Locally Advanced Soft Tissue Sarcoma
The First Affiliated Hospital with Nanjing Medical University 46
Testing effectiveness (Phase 2)Study completedNCT02235701
What this trial is testing

Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma

Who this might be right for
Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
ImmunityBio, Inc. 70
Early research (Phase 1)Study completedNCT03009201
What this trial is testing

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more
OHSU Knight Cancer Institute 16
Large-scale testing (Phase 3)Study completedNCT01440088
What this trial is testing

A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Threshold Pharmaceuticals 640
Large-scale testing (Phase 3)WithdrawnNCT03342300
What this trial is testing

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma

Who this might be right for
Progression-free SurvivalOverall SurvivalToxicity
Peking University People's Hospital
Testing effectiveness (Phase 2)UnknownNCT06384248
What this trial is testing

Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

Who this might be right for
Unresectable or Metastatic Sarcoma
Letolab 30
Testing effectiveness (Phase 2)Study completedNCT01310816
What this trial is testing

A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma

Who this might be right for
Conventional Chondrosarcoma
Infinity Pharmaceuticals, Inc. 105
Next Page